Drugs for Treating Congestive Heart Failure: Global Markets

Published - Oct 2011| Code - PHM102A| Analyst - Mary Anne Crandall

Report Highlights

The global market for congestive heart failure pharmaceuticals was valued at nearly $11.2 billion in 2010. This market is expected to reach nearly $12.2 billion in 2011 and $18.6 billion in 2016, a compound annual growth rate (CAGR) of 8.9% between 2011 and 2016.

SCOPE OF STUDY

This report is a comprehensive business tool designed to provide an in-depth look at drugs for the congestive heart failure market.  The geographic scope of the report is global with a special emphasis on individual regions.  The report describes the industry, its relationship to the healthcare industry and its participants, and trends for the future.

Categories discussed in the report include:

  • Angiotensin converting enzyme (ACE) inhibitors/angiotensin II receptor blocker antagonists (ARBs)
  • Beta-adrenergic receptor blocking agents
  • Diuretics
  • Inotropic  drugs/vasodilators

All categories are discussed in detail, describing each segment, identifying current products on the market, measuring market size, identifying market drivers, forecasting for 2010 to 2016, and assessing the competitors and competitor market shares.

ANALYST CREDENTIALS

Mary Anne Crandall is an expert industry analyst specializing in the pharmaceutical industry for the last 20 years.  She has completed several in-depth studies on various medical topics requiring both medical expertise and excellent knowledge of the pharmaceutical industry.  Ms. Crandall has extensive knowledge in the medical field, has an M.S. in psychology, and is currently working on a PhD.

Table of Contents & Pricing

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Note: Reports are discounted or included with certain Memberships. See Membership Options.
Title/Chapter Name Pages Price Member Price
Full Report: Drugs for Treating Congestive Heart Failure: Global Markets 184 $2,750 Free
Chapter- 1: INTRODUCTION3Free
Chapter- 2: EXECUTIVE SUMMARY4$250Free
Chapter- 3: OVERVIEW40$598Free
Chapter- 4: THE GLOBAL MARKET12$179Free
Chapter- 5: THE AMERICAS MARKET 26$389Free
Chapter- 6: THE EUROPEAN MARKET 20$299Free
Chapter- 7: THE ASIAN MARKET 13$194Free
Chapter- 8: REST-OF-WORLD/EMERGING MARKETS18$269Free
Chapter- 9: COMPANY PROFILES31$463Free
Chapter- 10: APPENDIX: DIRECTORY OF COMPANIES17$254Free
 
RELATED REPORTS
Share This Report